Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Merck & Company (MRK)

59.17 0.72 (1.23%)

05-23 16:00

Open:

58.45

Pre. Close:

58.45

High:

59.49

Low:

58.43

Volume:

9,900,427

Market Cap:

159185M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

59.575 - 59.909

59.909 - 60.214

Low:

57.54 - 57.981

57.981 - 58.385

Close:

58.533 - 59.17

59.17 - 59.754

Technical analysis  (as of: 2018-05-23 4:29:50 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 71.25     One year: 83.22

Support:

Support1: 58.07    Support2: 56.26

Resistance:

Resistance1: 61.00    Resistance2: 71.25

Pivot:

58.54

Moving Averages:

MA(5): 58.88     MA(20): 58.56

MA(100): 57.07     MA(250): 59.72

MACD:

MACD(12,26): 0.45     Signal(12,26,9): 0.52

%K %D:

%K(14,3): 64.66     %D(3): 66.29

RSI:

RSI(14): 56.17

52-Week:

High: 66.41  Low: 52.83  Change(%): -9.0

Average Vol(K):

3-Month: 1145365  10-Days 897540

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
MRK has closed below upper band by 32.7%. Bollinger Bands are 24.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-23T14:08:42-04:00
Merck (MRK) Investor Presentation - Slideshow

2018-05-23T12:28:47-04:00
High Rates And Inflation Could Pose A Systemic Risk To Biotech

2018-05-23T08:19:02-04:00
Merck's Keytruda increased survival in first-line lung cancer study

2018-05-23T06:45:00-04:00
Merck's KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment for Squamous Non-Small Cell Lung Cancer (NSCLC) in Pivotal Phase 3 KEYNOTE-407 Trial

2018-05-23T06:10:14-04:00
Eiger BioPharmaceuticals: Elucidating The Fundamentals Powering A Big Winner

2018-05-23T01:52:10-04:00
Reader Inquiry: Has Tesaro Finally Found A Bottom?

2018-05-22T14:23:32-04:00
Merck declares $0.48 dividend

2018-05-22T14:21:00-04:00
Merck Announces Third-Quarter 2018 Dividend

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

2690.30

Shares Float (M)

2687.27

% Held by Insiders

% Held by Institutions

78.00

Shares Short (K)

20403

Shares Short Prior Month (K)

16960

Stock Financials

EPS

4.150

EPS Est. Current Year

3.870

EPS Est. Next Year

4.160

EPS Est. Next Quarter

0.960

Forward EPS

4.551

Book Value (p.s.)

4.640

PEG Ratio

2.01

Profit Margin

3.89

Operating Margin

20.31

Return on Assets (ttm)

1.6

Return on Equity (ttm)

4.0

Qtrly Rev. Growth

3.1

Gross Profit (p.s.)

7.779

Sales Per Share

EBITDA (p.s.)

2.837

Qtrly Earnings Growth

Operating Cash Flow (M)

6450.00

Levered Free Cash Flow (M)

6550.00

atoplab.com

Valuation

P/E

14.26

P/E Growth Ratio

0.01

P/BV

12.75

P/S

10827706368.00

P/CF

24.68

Dividend Yield

0.05

Dividends & Splits

Dividend

3.217

Dividend Pay Date

2018-04-06

Ex-Dividend Date

2018-03-14

Forward Dividend

1.920

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.